Recall of TriForce Peripheral Crossing Set(intended to be percutaneously introduced into blood vessels and support a wire guide while performing percutaneous peripheral interventions)

According to Department of Health, Therapeutic Goods Administration, this recall involved a device in Australia that was produced by William A Cook Australia Pty Ltd.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    RC-2017-RN-00362-1
  • Event Risk Class
    Class I
  • Event Initiated Date
    2017-03-10
  • Event Country
  • Event Source
    DHTGA
  • Event Source URL
  • Notes / Alerts
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • Extra notes in the data
  • Reason
    There has been an increase in reports of blood loss associated with devices using a specific haemostatic valve design (referred to as the “blue” valve or polyisoprene valve). in november 2015, products manufactured with the haemostatic blue valve design were either made obsolete or changed to incorporate a different valve design with improved haemostasis. cook has continued to receive reports of blood loss associated with the earlier generation products containing the “blue” valve and therefore has initiated this action on those devices. potential adverse events that may occur if these devices are used in the arterial system include delay in procedure and blood loss. if devices are used in the central venous system, adverse events that may occur include delay in procedure, blood loss, or air embolism.
  • Action
    Customers are notified to quarantine and immediately return any affected product that remains unused to Cook Medical.

Device

  • Model / Serial
    TriForce Peripheral Crossing Set(intended to be percutaneously introduced into blood vessels and support a wire guide while performing percutaneous peripheral interventions)Catalogue Identified (Prefix/Suffix): KCXS-5.0- / -RB-0/0-HCKCXS-5.0- / -RB-0/DAV-HCKCXS-5.0- / -RB-MPB/0-HCKCXS-5.0- / -RB-MPB/DAV-HCAffected Lot Numbers: 6446148, 6446178, 6446172, 6446175, 6446166, 6446157, 6458182, 6446154ARTG Number: 246412
  • Product Classification
  • Manufacturer

Manufacturer